Engineering improvements in endovascular devices: Design and validation

Annals of the New York Academy of Sciences

Volumn 1085, Issue , 2006, Pages 213-223

  Williams, David M ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

Author keywords

Critical path research; Endografts; Food and Drug Administration (FDA)

Indexed keywords

AORTA ANEURYSM; ARTIFICIAL ORGAN; BIOINFORMATICS; BLOOD VESSEL GRAFT; CLINICAL PATHWAY; COMPUTER AIDED DESIGN; CONFERENCE PAPER; DEVICE; ENDOVASCULAR SURGERY; FOOD AND DRUG ADMINISTRATION; HUMAN; MEDICAL RESEARCH; MICROELECTROMECHANICAL SYSTEM; PATIENT CARE; TREATMENT PLANNING; ANEURYSM; BIOMEDICAL ENGINEERING; DRUG DESIGN; METHODOLOGY; MICROCIRCULATION; REVIEW; TIME;

ANEURYSM; BIOMEDICAL ENGINEERING; COMPUTER-AIDED DESIGN; DRUG DESIGN; HUMANS; MICROCIRCULATION; TIME FACTORS;

EID: 34447634675     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1383.021     Document Type: Conference Paper

References (9)

1. Innovation or Stagnation? 2004. Challenge and Opportunity on the Critical Path to New Medical Products. U.S. Department of Health and Human Services, Food and Drug Administration, Washington, D.C. Accessed October 20, 2006: http://www.fda.gov/oc/initiatives/criticalpath/whitepaper.html
2. Office of Device Evaluation Annual Report Fiscal Year 2004. March 2005. U.S. Department of Health and Human Services,Washington, D.C. Accessed October 20, 2006: http://www.fda.gov/cdrh/annual/fy2004/ode/part3.html
3. Korn D., Stanski D.R., Eds. Drug Development Science: Obstacles and Opportunities for Collaboration Among Academia, Industry and Government. Association of American Medical Colleges, AAMC-FDA Conference on Drug Development Science Report, January, 2005. Accessed October 20, 2006: https://services.aamc.org/Publications/index.cfm?fuseaction=Product. displayForm&prd id=135&prv_id=159
4. Innovation or Stagnation? Critical Path Opportunities List. U.S. Department of Health and Human Services, Food and Drug Administration, Washington, D.C. March 2006. Accessed October 20, 2006: http://www.fda.gov/oc/ initiatives/criticalpath/reports/opp_list.pdf
5. FDA's Science Forum Centennial Home Page. U.S. Department of Health and Human Services, Food and Drug Administration, Washington, D.C. Accessed October 20, 2006: http://www.fda.gov/scienceforum/
6. What is MEMS Technology. MEMS and Nanotechnology Clearinghouse. Accessed October 20, 2006: http://www.memsnet.org/mems/what-is.html
7. Figures for vascular access, lower extremity bypass, and abdominal aortic aneurysm repair procedures are available In The Dartmouth Atlas of Vascular Health Care. J.L. Cronenwett & J.D. Birkmeyer, Eds.: 8, 122, 142. AHA Press. Chicago. http://www.dartmouthatlas.org/atlases/atlas.series.shtm. (accessed May 3, 2006).
8. POH, M., M. BOYER, A. SOLAN, et al. 2005. Blood vessels engineered from human cells. Lancet. 365: 2122-2124.
9. HOENIG, M.R., G.R. CAMPBELL, B.E. ROLFE & J.H. CAMPBELL. 2005. Tissue-engineered blood vessels: alternative to autologous grafts? Arterioscler. Thromb. Vasc. Biol. 25: 1128-1134.